TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7661171

Group type: EXPERIMENTAL
Intervention: Misoprostol 200 micrograms
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Misoprostol 800 micrograms
Number of subjects: 26

Group type: COMPARATOR
Intervention: Indomethacin 50 mg
Number of subjects: 26
Study: 2484789

Group type: EXPERIMENTAL
Intervention: Single treatment of 8 Gy
Number of subjects: 29

Group type: COMPARATOR
Intervention: Conventional fractionation of 24 Gy in six fractions over two to three weeks
Number of subjects: 29

Group type: COMPARATOR
Intervention: Conventional fractionation of 24 Gy in six fractions
Number of subjects: 29
Study: 793780

Group type: EXPERIMENTAL
Intervention: 300 mg ketoprofen per day
Number of subjects: 30

Group type: COMPARATOR
Intervention: 150 mg indomethacin per day
Number of subjects: 30
Study: 31717901

Group type: EXPERIMENTAL
Intervention: Fibre supplementation (twice-a-day)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study: 28333707

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 48

Group type: COMPARATOR
Intervention: Saline Control
Number of subjects: 48
Study: 25933246

Group type: EXPERIMENTAL
Intervention: S-1 combined with cisplatin (SC)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Cisplatin alone (C)
Number of subjects: 72
Study: 24149005

Group type: EXPERIMENTAL
Intervention: Health Utility Score (HUS) > 0
Number of subjects: 2569

Group type: EXPERIMENTAL
Intervention: Health Utility Score (HUS) < 0
Number of subjects: 2569

Group type: EXPERIMENTAL
Intervention: Proxy responders
Number of subjects: 2569

Group type: EXPERIMENTAL
Intervention: Correlation with modified Rankin Scale
Number of subjects: 2569

Group type: EXPERIMENTAL
Intervention: Correlation with Barthel index
Number of subjects: 2569

Group type: EXPERIMENTAL
Intervention: Correlation with Zung depression score
Number of subjects: 2569

Group type: EXPERIMENTAL
Intervention: Correlation with baseline severity
Number of subjects: 2569

Group type: EXPERIMENTAL
Intervention: Modified Rankin Scale of 5
Number of subjects: 2569
Study: 21277837

Group type: EXPERIMENTAL
Intervention: Aceclofenac-CR (n = 143) once daily
Number of subjects: 285

Group type: COMPARATOR
Intervention: Conventional aceclofenac (n = 142) twice daily
Number of subjects: 285
Study: 19561174

Group type: EXPERIMENTAL
Intervention: Sports injury prevention training program
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (regular training program)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Comparison of experimental and control groups after training
Number of subjects: 22
Study: 17785487

Group type: EXPERIMENTAL
Intervention: Adherence to practice guidelines
Number of subjects: 1131
Study: 14998803

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 11778097

Group type: EXPERIMENTAL
Intervention: Continuous cervical plexus block with ropivacaine 0.75% 2.5 mg/kg
Number of subjects: 90

Group type: COMPARATOR
Intervention: Continuous cervical peridural anaesthesia with ropivacaine 0.5% 0.9 mg/kg and fentanyl 50-100 g
Number of subjects: 90
Study: 9424681

Group type: EXPERIMENTAL
Intervention: d‐tubocurarine 0.05 mg/kg
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: atracurium 0.05 mg/kg
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: vecuronium 0.01 mg/kg
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: pancuronium 0.015 mg/kg
Number of subjects: 124
Study: 7690527

Group type: EXPERIMENTAL
Intervention: Terfenadine, 120 mg bid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Terfenadine, 240 mg bid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ketotifen, 2 mg bid
Number of subjects: 0
Study: 2867269

Group type: EXPERIMENTAL
Intervention: Maximum education programme
Number of subjects: 339

Group type: EXPERIMENTAL
Intervention: Limited education programme
Number of subjects: 339

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 339
Study: 31540572

Group type: EXPERIMENTAL
Intervention: CABG + MVR
Number of subjects: 76

Group type: COMPARATOR
Intervention: Isolated CABG
Number of subjects: 76
Study: 29474290

Group type: COMPARATOR
Intervention: Standard counseling (handout)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Enhanced video counseling (handout plus video)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 200
Study: 27009342

Group type: COMPARATOR
Intervention: Environmental cleaning bundle (training, technique, product, audit, communication) implemented with environmental services staff
Number of subjects: 11

Group type: COMPARATOR
Intervention: Environmental cleaning bundle
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Cost-effectiveness analysis of the cleaning bundle
Number of subjects: 11
Study: 24832787

Group type: EXPERIMENTAL
Intervention: Circulating tumor cells (CTCs) detected before chemotherapy
Number of subjects: 2026

Group type: EXPERIMENTAL
Intervention: Circulating tumor cells (CTCs) detected after chemotherapy
Number of subjects: 2026

Group type: EXPERIMENTAL
Intervention: Presence of at least five CTCs per 30 mL blood
Number of subjects: 2026

Group type: EXPERIMENTAL
Intervention: Persisting CTCs after chemotherapy
Number of subjects: 2026
Study: 22503048

Group type: EXPERIMENTAL
Intervention: Collagenase Clostridium histolyticum
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Collagenase Clostridium histolyticum with modeling
Number of subjects: 147

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 147
Study: 19781043

Group type: EXPERIMENTAL
Intervention: 5 units of oxytocin
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: 10 units of oxytocin
Number of subjects: 103

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 103
Study: 17717284

Group type: EXPERIMENTAL
Intervention: Depression management program (algorithm-based care)
Number of subjects: 584

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 584
Study: 16328744

Group type: EXPERIMENTAL
Intervention: Teacher-consultation model social skills program (pre-K RECAP)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Comparison group (no specific intervention mentioned)
Number of subjects: 149
Study: 12692962

Group type: EXPERIMENTAL
Intervention: Chemotherapy combined with radiation therapy of the involved field (specific chemotherapy regimen not detailed, but mentions CHOP cycles).
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Short-course chemotherapy (3 cycles of CHOP) for low bulk tumors.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Full-course chemotherapy (6-8 cycles of CHOP) for larger tumors.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Involved field radiation (at least 30 Gy to sites in complete remission).
Number of subjects: 0
Study: 10779656

Group type: EXPERIMENTAL
Intervention: Oral dextromethorphan 150 mg
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study: 8638465

Group type: EXPERIMENTAL
Intervention: Laparoscopically assisted vaginal hysterectomy (LH)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Total abdominal hysterectomy (TAH)
Number of subjects: 100
Study: 1338225

Group type: EXPERIMENTAL
Intervention: Ganciclovir (12 patients)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control (11 patients)
Number of subjects: 23
Study: 6233379

Group type: EXPERIMENTAL
Intervention: Etretinate with whole milk (1 pint)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Etretinate with water
Number of subjects: 10
Study: 3134905

Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate treatment
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 29396662

Group type: EXPERIMENTAL
Intervention: MiSight contact lenses
Number of subjects: 89

Group type: COMPARATOR
Intervention: Single-vision spectacles
Number of subjects: 89
Study: 28927442

Group type: EXPERIMENTAL
Intervention: ACTI-BREAK programme (5-min bursts of moderate-intensity physical activity integrated into classroom routine, 3 times per day for 6 weeks)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: ACTI-BREAK programme
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control group (no active breaks)
Number of subjects: 6
Study: 26887521

Group type: EXPERIMENTAL
Intervention: Improved treatment group (400 µg folic acid daily from the day before the first dose to 21 days after the last dose, 500 µg vitamin B12 injection one day before the first dose and before each therapy cycle)
Number of subjects: 283

Group type: COMPARATOR
Intervention: Conventional treatment group (400 µg folic acid daily for 7 days before the first dose and continued until 21 days after the last dose, 1000 µg vitamin B12 injection at 7 days before the first dose and once per cycle for 3 cycles after the last dose)
Number of subjects: 283

Group type: EXPERIMENTAL
Intervention: Improved treatment group
Number of subjects: 283

Group type: COMPARATOR
Intervention: Conventional treatment group
Number of subjects: 283

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 283
Study: 24280477

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Acupressure
Number of subjects: 26
Study: 21174145

Group type: EXPERIMENTAL
Intervention: R 10 mg + FA 135 mg
Number of subjects: 456

Group type: EXPERIMENTAL
Intervention: R 20 mg + FA 135 mg
Number of subjects: 456

Group type: EXPERIMENTAL
Intervention: R 5 mg + FA 135 mg
Number of subjects: 456
Study: 18312649

Group type: EXPERIMENTAL
Intervention: Self‐Administered Mailed Questionnaire (SAMQ)
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: Computer‐Assisted Self‐Interview (CASI)
Number of subjects: 599

Group type: COMPARATOR
Intervention: Computer‐Assisted Telephone Interview (CATI)
Number of subjects: 599
Study: 16970600

Group type: EXPERIMENTAL
Intervention: Zidovudine (ZDV)
Number of subjects: 217

Group type: COMPARATOR
Intervention: No ART
Number of subjects: 217

Group type: COMPARATOR
Intervention: Other ART
Number of subjects: 217

Group type: COMPARATOR
Intervention: Weight-based RBV dosing
Number of subjects: 217
Study: 12720592

Group type: EXPERIMENTAL
Intervention: Oral nutritional supplementation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no nutritional supplementation)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Physical activity level
Number of subjects: 20
Study: 11096262

Group type: EXPERIMENTAL
Intervention: Sulfurated mud baths (6 applications over 2 weeks)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Tap water baths (6 applications over 2 weeks)
Number of subjects: 25
Study: 8881626

Group type: EXPERIMENTAL
Intervention: Ketamine 3 mg kg-1 nasally (group IN3)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Ketamine 9 mg kg-1 nasally (group IN9)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Ketamine 9 mg kg-1 rectally (group IR9)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Ketamine 3 mg kg-1 i.v. (group IV3)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Nasal ketamine (groups IN3 and IN9)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Rectal ketamine (group IR9)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Norketamine after nasal administration
Number of subjects: 32
Study: 1303639

Group type: EXPERIMENTAL
Intervention: Home visits from a nurse or social worker in addition to routine prenatal care (n = 1115)
Number of subjects: 2235

Group type: COMPARATOR
Intervention: Routine prenatal care (n = 1120)
Number of subjects: 2235
Study: 3890924

Group type: EXPERIMENTAL
Intervention: Ketoconazole (200 mg daily, doubled after 3 months if inadequate response)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Griseofulvin (500 mg daily, doubled after 3 months if inadequate response)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Ketoconazole
Number of subjects: 74

Group type: COMPARATOR
Intervention: Griseofulvin
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 74
Study: 29338639

Group type: EXPERIMENTAL
Intervention: Continuous Passive Motion (CPM) combined with Complete Decongestive Therapy (CDT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Complete Decongestive Therapy (CDT) alone
Number of subjects: 30
Study: 27538770

Group type: EXPERIMENTAL
Intervention: Titanium-prepared platelet-rich fibrin (T-PRF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 0
Study: 24215171

Group type: EXPERIMENTAL
Intervention: ABT-288 (10 dose levels, from 1 to 60 mg once daily for 14 days)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: ABT-288
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study: 22873187

Group type: EXPERIMENTAL
Intervention: Therapeutic community program
Number of subjects: 468

Group type: COMPARATOR
Intervention: Cognitive‐behavioral intervention
Number of subjects: 468
Study: 20929341

Group type: EXPERIMENTAL
Intervention: Margarine supplemented with EPA and DHA (targeted additional daily intake of 400 mg of EPA-DHA)
Number of subjects: 4837

Group type: EXPERIMENTAL
Intervention: Margarine supplemented with ALA (targeted additional daily intake of 2 g of ALA)
Number of subjects: 4837

Group type: COMPARATOR
Intervention: Margarine supplemented with ALA compared to placebo and EPA-DHA alone in women
Number of subjects: 4837

Group type: COMPARATOR
Intervention: Placebo margarine
Number of subjects: 4837
Study: 18569679

Group type: EXPERIMENTAL
Intervention: True memories
Number of subjects: 0

Group type: COMPARATOR
Intervention: False memories
Number of subjects: 0
Study: 15763436

Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (PGE1) infusion therapy
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 21
Study: 12858952

Group type: EXPERIMENTAL
Intervention: Saccade-to-target task
Number of subjects: 2

Group type: COMPARATOR
Intervention: Manual-target-detection task
Number of subjects: 2
Study: 9987142

Group type: EXPERIMENTAL
Intervention: Full-dose Mérieux BCG vaccine (lot E0650)
Number of subjects: 548

Group type: EXPERIMENTAL
Intervention: Full-dose Mérieux BCG vaccine (lot E0624)
Number of subjects: 548

Group type: EXPERIMENTAL
Intervention: Full-dose WHO-reference vaccine (Tokyo strain 172)
Number of subjects: 548

Group type: COMPARATOR
Intervention: 1/10 dose WHO-reference vaccine
Number of subjects: 548
Study: 7489845

Group type: EXPERIMENTAL
Intervention: Lovastatin (n = 16; mean dose 30.0 +/- 12.6 mg/day)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo (n = 18)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Lovastatin
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 34
Study: 2227746

Group type: EXPERIMENTAL
Intervention: Topical application of Ruscus extract (4 to 6 g of cream containing 64 to 96 mg Ruscus extract)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo (base of the cream)
Number of subjects: 18
Study: 369941

Group type: EXPERIMENTAL
Intervention: Sulproston 500 microgram IM
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Hegar's rods
Number of subjects: 50

Group type: COMPARATOR
Intervention: Physiological saline solution
Number of subjects: 50
Study: 31536566

Group type: EXPERIMENTAL
Intervention: Dialysis, NAF
Number of subjects: 10119

Group type: EXPERIMENTAL
Intervention: Dialysis, non-NAF
Number of subjects: 10119

Group type: EXPERIMENTAL
Intervention: Non-Dialysis, NAF
Number of subjects: 10119

Group type: COMPARATOR
Intervention: Non-Dialysis, non-NAF
Number of subjects: 10119

Group type: EXPERIMENTAL
Intervention: Peritoneal dialysis, AF
Number of subjects: 10119
Study: 29653541

Group type: EXPERIMENTAL
Intervention: TARGIT-IORT (single-dose intra-operative radiotherapy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: EBRT (whole breast external beam radiotherapy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nurse and doctor scores
Number of subjects: 0
Study: 26702749

Group type: EXPERIMENTAL
Intervention: Art therapy (6 painting sessions)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 60
Study: 25456558

Group type: EXPERIMENTAL
Intervention: Setrobuvir 200 mg BID
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Setrobuvir 400 mg BID
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Setrobuvir 800 mg BID
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 22013886

Group type: EXPERIMENTAL
Intervention: Telecare
Number of subjects: 241

Group type: COMPARATOR
Intervention: Conventional self-monitored blood glucose (SMBG)
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Both groups (Telecare and SMBG)
Number of subjects: 241
Study: 19280812

Group type: EXPERIMENTAL
Intervention: Abdominal binder
Number of subjects: 54

Group type: COMPARATOR
Intervention: No binder
Number of subjects: 54
Study: 17849093

Group type: EXPERIMENTAL
Intervention: Stent‐supported angioplasty (CAS)
Number of subjects: 1214

Group type: COMPARATOR
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 1214
Study: 15340127

Group type: EXPERIMENTAL
Intervention: lumiracoxib 400 mg/day
Number of subjects: 18

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 18
Study: 11595776

Group type: EXPERIMENTAL
Intervention: Orlistat therapy
Number of subjects: 18
Study: 9549655

Group type: EXPERIMENTAL
Intervention: (R)-ketoprofen 100 mg b.i.d.
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: (R)-flurbiprofen 100 mg b.i.d.
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: racemic ketoprofen 100 mg b.i.d.
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: paracetamol 1,000 mg b.i.d.
Number of subjects: 72

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 72
Study: 7803063

Group type: EXPERIMENTAL
Intervention: Practice models for applying the 1988 Adult Treatment Panel Guidelines
Number of subjects: 0
Study: 3044276

Group type: EXPERIMENTAL
Intervention: Carboplatin regimen
Number of subjects: 42

Group type: COMPARATOR
Intervention: Cisplatin regimen
Number of subjects: 42
Study: 31933034

Group type: EXPERIMENTAL
Intervention: Exercise group (12-week exercise programme, twice per week)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Exercise group
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32
Study: 29320589

Group type: EXPERIMENTAL
Intervention: Test Product (novel hyaluronic acid gel)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparator (non‐animal stabilized hyaluronic acid gel)
Number of subjects: 0
Study: 26786052

Group type: EXPERIMENTAL
Intervention: Wide-area circumferential pulmonary vein isolation (PVI)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Repeat electrophysiology study after 2 months
Number of subjects: 40
Study: 25018057

Group type: EXPERIMENTAL
Intervention: Methylene blue (260 mg)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 22998856

Group type: EXPERIMENTAL
Intervention: Real-time myocardial contrast echocardiography (RTMCE)
Number of subjects: 1776

Group type: COMPARATOR
Intervention: Non-RTMCE
Number of subjects: 1776

Group type: EXPERIMENTAL
Intervention: RTMCE
Number of subjects: 1776
Study: 20665986

Group type: EXPERIMENTAL
Intervention: Acrysof IQ
Number of subjects: 260

Group type: COMPARATOR
Intervention: Acrysof Natural
Number of subjects: 260
Study: 17872406

Group type: EXPERIMENTAL
Intervention: Aerobic exercise before resistance training (BRT)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Aerobic exercise after resistance training (ART)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Sedentary control (SED)
Number of subjects: 33
Study: 16204298

Group type: EXPERIMENTAL
Intervention: Self-reported appetite
Number of subjects: 1846
Study: 12371383

Group type: EXPERIMENTAL
Intervention: ISDN‐80
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: NITRO‐15
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: PENTA‐100
Number of subjects: 15

Group type: COMPARATOR
Intervention: P (Placebo)
Number of subjects: 15
Study: 8879603

Group type: EXPERIMENTAL
Intervention: beta-blocker + diuretics
Number of subjects: 6628

Group type: COMPARATOR
Intervention: ACE inhibitors
Number of subjects: 6628

Group type: COMPARATOR
Intervention: calcium antagonists
Number of subjects: 6628

Group type: EXPERIMENTAL
Intervention: All treatment arms
Number of subjects: 6628
Study: 2271853

Group type: EXPERIMENTAL
Intervention: Thiazide diuretics taken by 325 men for a mean of 11.9 years
Number of subjects: 1017

Group type: EXPERIMENTAL
Intervention: Other antihypertensive drugs taken by 53 men
Number of subjects: 1017

Group type: COMPARATOR
Intervention: Control group (639 men without hypertension)
Number of subjects: 1017
Study: 6968205

Group type: EXPERIMENTAL
Intervention: Vibratory angular acceleration (aR) at 1 Hz
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Vibratory angular acceleration (aR) at 5 Hz
Number of subjects: 14

Group type: COMPARATOR
Intervention: No vibratory angular acceleration (aR)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Constant aR presented for 0.5 and 1.0 s
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Vibratory aR conditions (1 Hz and 5 Hz)
Number of subjects: 14
Study: 31455938

Group type: EXPERIMENTAL
Intervention: Bag-and-mask ventilation with monitor displayed
Number of subjects: 82

Group type: COMPARATOR
Intervention: Bag-and-mask ventilation without monitor displayed
Number of subjects: 82
Study: 28369211

Group type: COMPARATOR
Intervention: GSK3532795 5-120 mg once daily for 10 days (Part A)
Number of subjects: 0

Group type: COMPARATOR
Intervention: GSK3532795 40 mg or 80 mg once daily with atazanavir (ATV) ± ritonavir (RTV) for 28 days (Part B)
Number of subjects: 0

Group type: COMPARATOR
Intervention: GSK3532795 40 mg or 120 mg once daily for 10 days (Part C)
Number of subjects: 0
Study: 26342888

Group type: EXPERIMENTAL
Intervention: 5-20mg escitalopram
Number of subjects: 28

Group type: COMPARATOR
Intervention: Matched healthy elderly (control group)
Number of subjects: 28
Study: 23722951

Group type: EXPERIMENTAL
Intervention: Real electroacupuncture (EA) twice weekly for 6 weeks
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sham electroacupuncture (EA) twice weekly for 6 weeks
Number of subjects: 32
Study: 21217439

Group type: EXPERIMENTAL
Intervention: Computer-assisted quantitative motion analysis (QMA) software
Number of subjects: 6

Group type: COMPARATOR
Intervention: Digitized manual technique
Number of subjects: 6
Study: 19201630

Group type: EXPERIMENTAL
Intervention: Palatal osteotomy
Number of subjects: 32

Group type: COMPARATOR
Intervention: Lateral osteotomy
Number of subjects: 32
Study: 17519278

Group type: EXPERIMENTAL
Intervention: Intensive treatment with methotrexate (MTX)
Number of subjects: 299

Group type: COMPARATOR
Intervention: Conventional treatment with methotrexate (MTX)
Number of subjects: 299